These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats. García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade. de Andrade Zorzi RL; Meirelles Pereira LM; Mandarim-de-Lacerda CA J Cell Mol Med; 2002; 6(4):599-608. PubMed ID: 12611644 [TBL] [Abstract][Full Text] [Related]
4. Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats. Pereira LM; Almeida JR; Mandarim-de-Lacerda CA Life Sci; 2004 Jan; 74(11):1375-86. PubMed ID: 14706568 [TBL] [Abstract][Full Text] [Related]
5. Short-term ACE inhibition confers long-term protection against target organ damage. Hale TM; Robertson SJ; Burns KD; deBlois D Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205 [TBL] [Abstract][Full Text] [Related]
6. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat. Yang Y; Macdonald GJ; Duggan KA Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats. Schulz A; Schütten-Faber S; Schulte L; Unland J; Kossmehl P; Kreutz R Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats. Bezerra DG; Mandarim-de-Lacerda CA Clin Sci (Lond); 2005 Apr; 108(4):349-55. PubMed ID: 15610072 [TBL] [Abstract][Full Text] [Related]
9. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. Olzinski AR; McCafferty TA; Zhao SQ; Behm DJ; Eybye ME; Maniscalco K; Bentley R; Frazier KS; Milliner CM; Mirabile RC; Coatney RW; Willette RN Cardiovasc Res; 2005 Apr; 66(1):170-8. PubMed ID: 15769460 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker. Saleh FH; Jurjus AR J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424 [TBL] [Abstract][Full Text] [Related]
11. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445 [TBL] [Abstract][Full Text] [Related]
12. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency. Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975 [TBL] [Abstract][Full Text] [Related]
14. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure. Secchi J; Lecaque D; Dunn FW; Jouquey S; Auberval UD; Benzoni F; Sirugue O; Hamon G J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S30-7. PubMed ID: 7527099 [TBL] [Abstract][Full Text] [Related]
15. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril. Bernátová I; Pechánová O; Pelouch V; Simko F J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795 [TBL] [Abstract][Full Text] [Related]
17. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Bernátová I; Pechánová O; Simko F Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706 [TBL] [Abstract][Full Text] [Related]
18. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778 [TBL] [Abstract][Full Text] [Related]
19. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril. Ledingham JM; Laverty R Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398 [TBL] [Abstract][Full Text] [Related]
20. Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats. Afkir S; Nguelefack TB; Aziz M; Zoheir J; Cuisinaud G; Bnouham M; Mekhfi H; Legssyer A; Lahlou S; Ziyyat A J Ethnopharmacol; 2008 Mar; 116(2):288-95. PubMed ID: 18191352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]